-
hCG–CXCL10 Regulation by Histone Methylation
2026-08-19
Silasi and colleagues show that human chorionic gonadotropin represses CXCL10 in human decidual stromal cells by promoting EZH2-associated H3K27me3 deposition at a defined CXCL10 promoter region. The study connects trophoblast-derived hormonal signaling with chromatin remodeling and CD8 T-cell recruitment, providing a mechanistic framework for epigenetic regulation research at the maternal–fetal interface.
-
RSV NS3 Hijacks Signaling to Balance Pathogenicity
2026-08-18
Zhuang et al. show that Rice stripe virus NS3 switches between distinct interaction and phosphorylation states to coordinate viral pathogenicity, transmission, and host survival. The study identifies the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway as a regulatory hub linking calcium signaling, reactive oxygen species, programmed cell death, and antiviral RNA interference across rice, planthopper, and wheat systems.
-
MEG3, TGF-β, and NiO Nanoparticle Pulmonary Fibrosis
2026-08-18
The reference study identifies lncRNA MEG3 as a suppressor of nickel oxide nanoparticle-induced pulmonary fibrosis and links its loss to TGF-β1-driven PI3K/AKT activation. Its combined rat, A549-cell, inhibitor, and gene-overexpression design provides a mechanistic framework for studying how nanoparticle exposure promotes collagen deposition.
-
Angiotensin 1/2 (1-6) in RAS Assays
2026-08-17
Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, gives researchers a defined input for vascular, renal, and receptor-binding experiments. This guide connects practical handling and dose-response workflows with a recent finding that shorter angiotensin fragments can enhance spike–AXL binding, while clearly separating established evidence from assay-development recommendations.
-
Exendin-4 Workflows for Beta Cell Research
2026-08-16
Exendin-4, also known as Exenatide, connects receptor-proximal cAMP signaling with functional insulin secretion assays. This guide pairs practical beta cell workflows with a yeast-expression strategy that may improve reagent accessibility for type 2 diabetes research.
-
Rapamycin (Sirolimus) Research Workflows
2026-08-15
Rapamycin (Sirolimus) offers a precise way to interrogate mTOR-dependent growth, immune activation, differentiation, and metabolic phenotypes. This practical guide connects concentration-controlled assays with a Langerhans cell histiocytosis finding that shows why treatment timing can determine whether mTOR inhibition suppresses or reinforces a disease-associated marker program.
-
Salmonella Haem, Phagocytosis, and Virulence
2026-08-15
A recent Nature Microbiology study identifies SirM-mediated methylation of HemL as a regulatory mechanism that increases Salmonella haem biosynthesis and suppresses macrophage phagocytosis. The work links bacterial haem production to TLR4-dependent inhibition of Cdc42, macrophage death, and enhanced virulence in mice, extending haem biology beyond iron acquisition.
-
Tofacitinib Citrate: Applied JAK3 Workflows
2026-08-14
Tofacitinib citrate enables concentration-resolved studies of lymphocyte signaling, cytokine production, and inflammatory endothelial responses. This practical guide combines immune-cell workflows with vascular safety readouts so researchers can separate pathway modulation from cytotoxicity and dose-related artifacts.
-
Cy5 Goat Anti-Mouse IgG (H+L) in Cell Assays
2026-08-14
Learn how Cy5 Goat Anti-Mouse IgG (H+L) Antibody, SKU K1210, supports reproducible immunofluorescence and flow-cytometry workflows alongside cell viability, proliferation, and cytotoxicity assays. Scenario-based guidance covers compatibility, optimization, interpretation, storage, and vendor selection.
-
JNK-IN-7 and Infection-Driven Apoptosis
2026-08-13
JNK-IN-7 offers a mechanistically precise way to test whether JNK activity links fungal recognition to epithelial apoptosis. This translational perspective connects Candida krusei biology with selective kinase perturbation, assay design, and pathway-specific interpretation.
-
Plk1 Control of p31comet in Checkpoint Disassembly
2026-08-13
The reference study identifies Polo-like kinase 1 (Plk1) as a direct regulator of p31comet, a factor that works with TRIP13 to disassemble mitotic checkpoint complexes. Its biochemical and mutational evidence supports a model in which Plk1 phosphorylation of p31comet at S102 restrains checkpoint disassembly during mitosis and limits futile cycling between checkpoint assembly and disassembly.
-
Nile Red as a Translational Lipid Map
2026-08-12
Nile Red, also known as Nile blue oxazone, can move lipid research beyond endpoint staining by linking droplet phenotypes to autophagy, lysosomal function, and translational decision-making. This thought-leadership guide explains how to use dual-channel fluorescence, rigorous controls, and orthogonal assays to interpret lipid storage dynamics in preclinical research.
-
Tomivosertib Inhibition in Acute Myeloid Leukemia
2026-08-12
Suarez and colleagues showed that selective MNK1/2 inhibition with Tomivosertib suppresses eIF4E Ser209 phosphorylation, AML cell viability, and leukemic progenitor colony formation. The study also identified synergistic activity with Venetoclax and used proteomics to investigate MNK-associated protein complexes, providing a framework for biomarker-guided combination research.
-
Resazurin Cell Viability Kit in Bone Research
2026-08-11
The Resazurin Cell Viability Assay Kit provides fluorescence- or color-based quantification of viable cells through resazurin reduction to resorufin. Its sensitivity and non-toxic workflow can support cell-level studies of Wnt-driven bone biology, but it does not replace osteogenic, molecular, or microcomputed-tomography endpoints.
-
p-Cresyl Sulfate and Aortic Valve Calcification
2026-08-10
The 2026 reference study identifies p-cresyl sulfate as a direct enhancer of calcification in aortic valvular interstitial cells and links this effect to HIF-1α activation, klotho loss, and impaired SIRT1-associated signaling. Its combined porcine cell and rat chronic kidney disease models suggest that klotho and SIRT1 activation may interrupt PCS-associated NF-κB/RUNX2 signaling, while also defining important limits for translation to human calcific aortic valve disease.
444 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page